Relationship Between Provider Volume and Outcomes For Orthotopic Liver Transplantation
โ Scribed by John E. Scarborough; Ricardo Pietrobon; Janet E. Tuttle-Newhall; Carlos E. Marroquin; Bradley H. Collins; Dev M. Desai; Paul C. Kuo; Theodore N. Pappas
- Book ID
- 107410364
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 137 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1091-255X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The current United Network for Organ Sharing (UNOS) policy is to allocate liver grafts to pediatric patients with chronic liver disease based on the pediatric end-stage liver disease (PELD) scoring system, while children with fulminant hepatic failure may be urgently listed as Status 1a. The objecti
Between 1986 and 1990 we performed heterotopic liver transplantation (HLT) in 17 patients with chronic liver disease. In spite of theoretical advantages and favorable short-term results, we abandoned HLT because of doubts about the long-term outcome and the improved results of standard orthotopic li
Hepatic sarcoidosis is a rare indication for liver transplantation. Using the United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN) database, we evaluated patient and graft survival after orthotopic liver transplantation for sarcoidosis between October 1987 and
Interferon (IFN) therapy with or without ribavirin treatment is well established as a standard antiviral treatment for hepatitis C virus (HCV)-infected patients. However, susceptibility to thrombocytopenia is a major obstacle for initiating or continuing this therapy, particularly in liver transplan